licensing

Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa

• People and Community

Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa

AETOSWire October 14, 2023

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive license...

Read More Read more about Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa

Hikma and Cosmo partner on exclusive licensing agreement for Winlevi® (Clascoterone) for the Middle East and North Africa

• General

Hikma and Cosmo partner on exclusive licensing agreement for Winlevi® (Clascoterone) for the Middle East and North Africa

AETOSWire October 2, 2023

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive license agreement with...

Read More Read more about Hikma and Cosmo partner on exclusive licensing agreement for Winlevi® (Clascoterone) for the Middle East and North Africa

Hoffmann Green Signs Its First Licensing Agreement in Saudi Arabia With the Shurfah Group

• People and Community

Hoffmann Green Signs Its First Licensing Agreement in Saudi Arabia With the Shurfah Group

AETOSWire September 5, 2023

CHAILLÉ-SOUS-LES-ORMEAUX, France — Hoffmann Green Cement Technologies (ISIN: FR0013451044, Mnemo: ALHGR) (Paris:ALHGR) (“Hoffmann Green Cement” or the...

Read More Read more about Hoffmann Green Signs Its First Licensing Agreement in Saudi Arabia With the Shurfah Group

Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle East and North Africa

• Health and Family

Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle East and North Africa

AETOSWire August 11, 2023

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive licensing and...

Read More Read more about Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle East and North Africa

Adapt to Business Changes with Flexible Licensing

• People and Community

Adapt to Business Changes with Flexible Licensing

NewsVoir July 27, 2023

By John Maddison – EVP of Products and CMO at Fortinet Dubai, United Arab Emirates When it...

Read More Read more about Adapt to Business Changes with Flexible Licensing

Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region

• People and Community

Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region

AETOSWire January 3, 2023

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces a new exclusive licensing agreement...

Read More Read more about Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region

Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region

• People and Community

Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region

AETOSWire December 27, 2022

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces a new exclusive...

Read More Read more about Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region

Hikma and Celltrion Healthcare sign exclusive licensing agreement for ustekinumab for the Middle East and North Africa region

• People and Community

Hikma and Celltrion Healthcare sign exclusive licensing agreement for ustekinumab for the Middle East and North Africa region

AETOSWire November 30, 2022

London, England — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces a new exclusive licensing agreements with...

Read More Read more about Hikma and Celltrion Healthcare sign exclusive licensing agreement for ustekinumab for the Middle East and North Africa region

House of Pops Participates at Private Label and Licensing ME

• Food and Restaurants

House of Pops Participates at Private Label and Licensing ME

NewsVoir November 8, 2022

Leading healthy snack brand brings ‘happiness on a stick’ to region’s biggest private labelling event Dubai, United...

Read More Read more about House of Pops Participates at Private Label and Licensing ME

Hikma and Adalvo Sign Exclusive Licensing Agreement to Commercialise Allergic Rhinitis Medication across MENA Markets

• People and Community

Hikma and Adalvo Sign Exclusive Licensing Agreement to Commercialise Allergic Rhinitis Medication across MENA Markets

AETOSWire August 25, 2022

Amman, Jordan — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive licensing agreement with...

Read More Read more about Hikma and Adalvo Sign Exclusive Licensing Agreement to Commercialise Allergic Rhinitis Medication across MENA Markets